Shandong Newleaf Chemical Co., Ltd. Class A

Shandong Newleaf Chemical Co., Ltd. Class A

SSZSE:002476
4.47
CNY
-0.22
(-4.69%)
0.03EPS
186.58P/E
2.97BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.12
1.09
1.21
1.47
0.67
0.74
0.68
0.73
1.07
0.97
0.64
0.88
0.99
1.04
Basic EPS, GAAP
0.08
0.08
0.04
0.02
0.01
-0.43
0.15
0.02
0.03
0.05
0.01
0.09
0.05
0.03
Free Cash Flow per Basic Share
0.04
-0.25
-0.16
0.05
- -
0.03
0.07
0.02
-0.09
-0.15
0.19
0.04
0.01
- -
Dividend per Share
0.03
0.03
0.04
0.04
0.03
0.02
0.01
0.02
0.01
- -
- -
0.01
0.01
0.01
Book Value per Share
1.63
1.66
1.66
1.61
1.61
1.17
1.32
1.34
1.37
1.42
1.43
1.51
1.55
1.59
Tangible Book Value per Share
1.6
1.59
1.59
1.55
1.55
1.11
1.3
1.32
1.36
1.4
1.42
1.5
1.54
1.58
Basic Weighted Avg Shares
612
612
613
613
613
612
612
613
613
612
609
612
612
612
Sales/Revenue/Turnover
685
668
742
898
410
450
417
447
657
592
387
539
603
637
Operating Margin (%)
8.36
7.81
3.79
2.57
-14.56
-5.84
-5.5
5.69
3.54
4.86
-6.23
3.68
4.4
4.11
Depreciation Expense
36
42
73
64
41
51
45
41
39
35
25
22
19
- -
Net Income, GAAP
47
48
24
15
8
-264
91
13
18
30
5
56
31
16
Effective Tax Rate (%)
16.6
19.3
392.93
189.64
81.63
- -
1.24
22.68
- -
4.42
50.8
8.71
15.03
16.09
Profit Margin (%)
6.85
7.18
3.25
1.65
2.02
-58.7
21.89
2.95
2.73
5.01
1.35
10.47
5.19
2.5
Working Capital
562
609
425
400
485
462
418
460
604
593
531
772
790
816
LT Debt
- -
- -
- -
43
64
38
8
78
- -
- -
- -
- -
- -
- -
Total Equity
1,003
1,136
1,101
1,036
988
718
809
822
840
870
877
927
950
972
Return on Invested Capital (%)
4.68
4.35
4.99
0.09
-0.02
- -
-2.95
1.49
- -
3.46
0.6
5.49
3.05
1.64
Return on Capital (%)
4.52
4.44
3.85
2.62
1.48
- -
11.53
2.28
- -
3.5
0.62
6.14
3.37
1.7
Return on Common Equity (%)
4.78
4.76
2.37
1.48
0.84
-30.96
11.96
1.62
2.16
3.47
0.6
6.25
3.34
1.67

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
17
25
15
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
612
612
612
Market Capitalization
4,431
3,507
2,974

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
975
986
977
Cash, Cash Equivalents & STI
495
448
500
Accounts Receivable, Net
228
311
226
Inventories
158
96
163
Total Current Liabilities
185
179
161
Payables & Accruals
- -
- -
- -
ST Debt
17
25
15
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.87%
2.96%
2.52%
Free Cash Flow
63.54%
-154.62%
-80.85%
Net Income, GAAP
-264.37%
190.48%
-44.46%
Sales/Revenue/Turnover
3%
10.7%
12%
Total Cash Common Dividend
97.03%
191.19%
7.43%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
134
78
174
153
539
2025
128
140
- -
151
603
2026
227
119
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
0.03
0.05
0.09
2025
0.02
- -
- -
-0.01
0.05
2026
0.02
0.01
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
- -
0.01
2025
- -
0.01
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Company Description

CEO
Ding Li
Full Time Employees
435
Sector
Process industries
Industry
Chemicals: major diversified
Address
No. 892 Xisi Road, Dongying District Shenzhen GD China 257081
IPO Date
Aug 31, 2010
Business
Shandong Polymer Biochemicals Co Ltd (002476.SZ) is a China-based company principally engaged in the research, development, manufacture and sale of fine chemicals and environmental water treatment products. The company offers core products including acrylamide, polyacrylamide, surfactants, heavy oil viscosity reducers, monomers, surface active agents and polymers; it also provides oilfield stimulation and oil recovery technical services as well as environmental protection water treatment products and technical services. Founded in 1996 and headquartered in Dongying, Shandong province, the company operates primarily in China with international sales of special chemicals for oil and gas exploitation. In recent developments, its subsidiary Baomo Environment was selected for China Petroleum & Chemical Corporation's 2025 framework agreement bidding list for Type II polyacrylamide products; the company reported operating income of 268 million yuan in the first half of 2025; and a subsidiary completed deregistration as part of ongoing operational adjustments. Shandong Polymer Biochemicals focuses on energy and environmental protection themes, leveraging proprietary technologies in microbial catalysis, copolymerization and polymer synthesis engineering.